Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor Mobilizers
NCT02682953Phase 2Withdrawn
- Sponsor
- University of Maryland, Baltimore
- Start
- Oct 2015
- Primary completion
- Feb 2017
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in multiple myeloma (MM) and lymphoma, sponsored by University of Maryland, Baltimore. Primary endpoint: Number of patients who adequately mobilize stem cells to undergo bone marrow transplantation. Planned start Oct 2015; status: withdrawn.
02
Conditions
multiple myeloma (MM)lymphoma
Beyond the preview
Go deeper on NCT02682953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02682953.